Terpenoid separated from purslane and preparation method and application thereof

CN119707879AActive Publication Date: 2025-03-28ZHEJIANG LINI BIOTECHNOLOGY CO LTD +1
3 Cites 1 Cited by

Patent Information

Application Number
CN202411891557.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-12-20
Publication Date
2025-03-28
Estimated Expiration
2044-12-20

AI Technical Summary

Technical Problem

但是目前对马齿苋的抗炎作用还未完全阐明,马齿苋的抗炎活性成分还不十分清楚

Benefits of technology

[0026]1、本发明首次从马齿苋中分离得到一种结构新颖的萜类化合物(1S,3R,5R,6S)-1-carboxy-3-hydroxy-5,6-epoxy-6-(3-methyl-2-(Z)-4-(E)-dien-valeric acid)-ionone,该萜类化合物结构明确,且具有强的抗炎活性,具备制成抗炎药物的潜力。

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention belongs to the technical field of medicines, and particularly relates to terpenoids separated from purslane as well as a preparation method and application of the terpenoids. The chemical structural formula of the terpenoid is as shown in formula 1), a total extract of portulaca oleracea is firstly extracted, organic solvents with different polarities are used for extracting the total extract of the portulaca oleracea to obtain a petroleum ether layer, an ethyl acetate layer and an n-butyl alcohol layer, the ethyl acetate layer is repeatedly eluted through a silica gel column, an ODS reversed-phase column and a gel column, and the terpenoid is obtained. According to the present invention, the terpenoid is obtained through the isocratic elution of the collected same fraction through the HPLC chromatographic column and separation, and the terpenoid is obtained for the first time and shows the significant anti-inflammatory activity in vitro, such that the new choice is provided for the development of the natural anti-inflammatory drug. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art